Arkolith/Insider Trading/NBIX/Form 4

Delaet Ingrid

Chief Regulatory OfficerNEUROCRINE BIOSCIENCES INC (NBIX) · full profile →Form 4 · filed Jul 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$791K
Net Open-Market Flow
-$791K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2026Option exercise(M)4K$106.02$463K21K
Jul 10, 2026Sell(S)4K$181.02$791K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 10, 2026Option exercise(M)4K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001965808-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML